关注
Minghui Liu
Minghui Liu
Postdoctoral Fellow, MD Anderson Cancer Center
在 mdanderson.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activity
H Yao, M Liu, L Wang, Y Zu, C Wu, C Li, R Zhang, H Lu, F Li, S Xi, S Chen, ...
Cell Research 32 (6), 570-584, 2022
362022
Optimization of NAMPT activators to achieve in vivo neuroprotective efficacy
L Wang, M Liu, Y Zu, H Yao, C Wu, R Zhang, W Ma, H Lu, S Xi, Y Liu, ...
European Journal of Medicinal Chemistry 236, 114260, 2022
142022
Blockade of CD24 sensitizes pancreatic cancer to Kras inhibitors
Y Wei, M Liu, EY Yen, J Yao, PT Nguyen, X Wang, Z Yang, A Yousef, ...
Cancer Research 84 (6_Supplement), 6532-6532, 2024
2024
Abstract C097: KRASG12C exhibits allele-specific biology in pancreatic cancer and targeting CD24 sensitizes KRASG12C-driven tumors to sotorasib treatment
Y Wei, M Liu, PT Nguyen, DN Pan, W Yao, H Ying
Cancer Research 84 (2_Supplement), C097-C097, 2024
2024
KRAS inhibition activates an actionable CD24 do-not-eat-me signal in pancreas cancer
Y Wei, M Liu, EY Yen, J Yao, PT Nguyen, X Wang, Z Yang, A Yousef, ...
bioRxiv, 2023.09. 21.558891, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–5